- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01278589
Antioxidative Effect of Plantago Asiatica L. Extract
October 27, 2011 updated by: Oran Kwon, Ewha Womans University
Acute Effect of Plantago Asiatica L. Extract on Antioxidative Biomarkers in Subjects With Mild Hyperlipidemia: A Pilot Study
The purpose of this study is to evaluate the antioxidant effect of Plantago asiatica L. extract in subjects with mild hyperlipidemia.
Study Overview
Status
Completed
Conditions
Detailed Description
The purpose of this study is to evaluate an acute effect of Plantago asiatica L. extract consumption on antioxidative biomarkers in subjects with mild hyperlipidemia.
Subjects will intake Plantago asiatica L. extract with a high fat meal for oxidative stress loading.
Antioxidative biomarkers will be measured after single-dose administration of Plantago asiatica L. extract.
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Ewha Womans University / Hanaro Medical Foundation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults age over 30
- BMI(Body mass index) between 25 and 33 kg/m2
- Total cholesterol between 200mg/dL and 250mg/dL OR Triglyceride between 150mg/dL and 220mg/dL OR LDL-cholesterol between 130mg/dL and 165mg/dL
Exclusion Criteria:
- Subject who has taken part in other clinical trials within 30 days of screening visit
- Subject who has taken medicines, Chinese medicines and Health/Functional Foods which can affect antioxidative biomarkers within 30days of screening visit
- Subject who is pregnant or breast feeding
- Subject who lost body weight over 4kg within 30days of screening visit
- Alcoholic
- Smoker
- Subject who takes excessive exercise (over 7hours/week)
- Subject who has hypertension(≥140/90mmHg), diabetes(fasting blood glucose ≥126mg/dL), kidney disease, hepatic disease or hyperthyroidism within 2years
- Subject who has an allergy to the ingredients of study product
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: Placebo
|
Liquid (80g) without Plantago asiatica L. extract
|
EXPERIMENTAL: • Plantago asiatica L. extract 5g
|
Liquid (80g) containing Plantago asiatica L. extract 5g
|
EXPERIMENTAL: Plantago asiatica L. extract 10g
|
Liquid (80g) containing Plantago asiatica L. extract 10g
|
EXPERIMENTAL: Plantago asiatica L. extract 20g
|
Liquid (80g) containing Plantago asiatica L. extract 20g
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Comet assay after single-dose consumption of Plantago asiatica L. extract
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Plasma FRAP
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
Plasma MDA
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
Plasma FFA
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
Plasma ox-LDL
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
Plasma erythrocyte SOD
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
Plasma triglyceride
Time Frame: measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
measured 5 times over 6 hours(0, 60, 120, 240, 360 minutes)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic Biol Med. 1990;8(6):583-99. doi: 10.1016/0891-5849(90)90156-d.
- Liu X, Wu X, Huang H, Zhong S, Lai X, Cao L. [Herbalogical study on Plantago asiatica L]. Zhong Yao Cai. 2002 Jan;25(1):46-8. Chinese.
- Choi SY, Jung SH, Lee HS, Park KW, Yun BS, Lee KW. Glycation inhibitory activity and the identification of an active compound in Plantago asiatica extract. Phytother Res. 2008 Mar;22(3):323-9. doi: 10.1002/ptr.2316.
- Chung MJ, Park KW, Kim KH, Kim CT, Baek JP, Bang KH, Choi YM, Lee SJ. Asian plantain (Plantago asiatica) essential oils suppress 3-hydroxy-3-methyl-glutaryl-co-enzyme A reductase expression in vitro and in vivo and show hypocholesterolaemic properties in mice. Br J Nutr. 2008 Jan;99(1):67-75. doi: 10.1017/S0007114507798926. Epub 2007 Aug 15.
- Xu C, Luo L, Tan RX. Antidepressant effect of three traditional Chinese medicines in the learned helplessness model. J Ethnopharmacol. 2004 Apr;91(2-3):345-9. doi: 10.1016/j.jep.2004.01.012.
- Lee SJ. Korean folk medicine. Publishing center of Seoul National Unicersity, Seoul. P 130, 1966
- Jeong CH, Bae YI, Shim KH, Choi JS. DPPH radical scavenging effect and antimicrobial activities of Plantain (Plantago asiatica L.) extracts. J Korean Soc Food Sci Nutr 33(10): 1601-1605, 2004
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Primary Completion (ACTUAL)
April 1, 2011
Study Completion (ACTUAL)
September 1, 2011
Study Registration Dates
First Submitted
January 18, 2011
First Submitted That Met QC Criteria
January 18, 2011
First Posted (ESTIMATE)
January 19, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
October 28, 2011
Last Update Submitted That Met QC Criteria
October 27, 2011
Last Verified
October 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- PLA_Biofood
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oxidative Stress
-
University of SouthamptonEuropean Space AgencyActive, not recruiting
-
University of ThessalyActive, not recruiting
-
NestléCompleted
-
University of BirminghamCompleted
-
University of KentuckyAlltech Life Sciences Inc.Completed
-
Ganin Fertility CenterThe Cleveland Clinic; University of the Western CapeUnknown
-
Antalya Training and Research HospitalCompleted
-
Gazi UniversityCompleted
-
Chinese University of Hong KongCompleted
-
Seoul St. Mary's HospitalRural Development Administration, KoreaCompletedOxidative StressKorea, Republic of
Clinical Trials on Plantago asiatica L. extract 5g
-
Mustafa Balevi,MDKonya Numune HospitalCompletedTo Prevent Scar Formation for Patients Underwent SurgeryTurkey
-
Oregon Health and Science UniversityActive, not recruiting
-
Oregon Health and Science UniversityNational Center for Complementary and Integrative Health (NCCIH)TerminatedCognitive Impairment | ElderlyUnited States
-
Indonesia UniversityUnknownDiabetes Mellitus, Type 2 | Xerosis CutisIndonesia
-
Chonbuk National University HospitalUnknownBlood FlowKorea, Republic of
-
Instituto de Ciencia y Tecnología de Alimentos...Ministerio de Economía y Competitividad, SpainCompleted
-
Hanyang UniversityActive, not recruitingUpper Respiratory InfectionKorea, Republic of
-
Shandong Luye Pharmaceutical Co., Ltd.Unknown
-
Laboratorios Leti, S.L.CompletedAllergic RhinoconjunctivitisSouth Africa
-
Hanyang UniversityCompletedObesityKorea, Republic of